[Clinical evaluation of Teronac (mazindol) in the treatment of obesity in children. Part II. Anorectic properties and side effects (author's transl)].
D000293:Adolescent; D001066:Appetite / Q000187:drug effects; D002648:Child; D002986:Clinical Trials as Topic; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D008454:Mazindol / Q000009:adverse effects / Q000627:therapeutic use*; D009765:Obesity / Q000188:drug therapy*; D010919:Placebos
D007211:Indoles; D010919:Placebos; D008454:Mazindol
Ocena kliniczna leku Teronac (mazindol) w leczeniu dzieci otyłych. Cz. II. Ocena właściwości anorektycznych i działania ubocznego.